ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

NCT05071937 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer

Interventions

DRUG: ZEN003694
DRUG: Talazoparib

Sponsor

Alexander B Olawaiye, MD

Collaborators

[object Object]
[object Object]